Gudgesic SP 100mg/325mg/15mg Tablet is a combination analgesic formulation containing Aceclofenac 100mg, Paracetamol 325mg, and Serratiopeptidase 15mg, designed to provide effective relief from pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis responsible for pain and inflammation. Paracetamol acts as an analgesic and antipyretic agent, providing additional pain relief and fever reduction through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and inflammation by enhancing fibrinolytic activity. This combination is indicated for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains, strains, and postoperative inflammation. Gudgesic SP is particularly beneficial in conditions where both pain and inflammation coexist, providing symptomatic relief and improving patient mobility. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, bleeding disorders, and severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risk factors. Regular monitoring and adherence to prescribed dosage are essential to minimize adverse effects.